BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Lian XF, Lu DH, Liu HL, Liu YJ, Yang Y, Lin Y, Xie F, Huang CH, Wu HM, Long AM, Hui CJ, Shi Y, Chen Y, Gao YF, Zhang F. Safety evaluation of human umbilical cord-mesenchymal stem cells in type 2 diabetes mellitus treatment: A phase 2 clinical trial. World J Clin Cases 2023; 11(21): 5083-5096 [PMID: 37583846 DOI: 10.12998/wjcc.v11.i21.5083]
URL: https://www.wjgnet.com/2307-8960/full/v11/i21/5083.htm
Number Citing Articles
1
Ayyub Ali Patel, Asma'a H. Mohamed, Jasur Rizaev, Ayaz Khurram Mallick, Maytham T. Qasim, Waleed Al Abdulmonem, Azfar Jamal, Haroonrashid M. Hattiwale, Mohammad Azhar Kamal, Fuzail Ahmad. Application of mesenchymal stem cells derived from the umbilical cord or Wharton’s jelly and their extracellular vesicles in the treatment of various diseasesTissue and Cell 2024; 89: 102415 doi: 10.1016/j.tice.2024.102415
2
Wenjing Xia, Hua Yu, Xia Lei, Pengcheng Wen. Effect of liraglutide on cardiac function in patients with type 2 diabetes mellitus: A systematic review and meta-analysis of double-blind, randomized, placebo-controlled trialsMedicine 2024; 103(11): e37432 doi: 10.1097/MD.0000000000037432